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treatment of LM disease, PCI with DES and CABG have comparable
mortality (all cause and cardiovascular) during long-term follow-up.
PCI with DES appears to be associated with increased risks of MI and
repeat revascularization.
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BACKGROUND According to the most recent guidelines, percuta-
neous coronary intervention (PCI) with drug eluting stents (DES)
should be considered safe and effective alternative to coronary artery
bypass grafting (CABG) for the treatment of left main (LM) disease in
patients with favorable anatomy (SYNTAX score 32). Conversely in
those with more complex coronary disease (SYNTAX>33) CABG is
favored mainly due to lower rates of revascularization and myocardial
infarction. However, whether the latter it is translated into long-term
mortality beneﬁt it is not clear and merits further investigation.
METHODS A systematic review of the MEDLINE, EMBASE, EBSCO,
CINAHL, Web of Science and COCHRANE databases was conducted in
May 2015. Studies reporting long-term outcomes (at least 4 years
mean follow up) of PCI with DES to CABG for LM disease stratiﬁed by
SS were identiﬁed. Patients were categorized to low/intermediate
(SS32) and high score (SS>33) groups. Random-effects meta-analyses
were performed using risk ratios as the metric of choice.
RESULTS Four studies comprising two randomized control trials
(SYNTAX and PRECOMBAT) and two observational studies (Main-
compare and CREDO-Kyoto), with a total of 3372 patients were
included. 1248 patients (37%) had complex coronary artery disease
(SS>33). Over a mean follow up of 4.9 years, no signiﬁcant difference
in all-cause mortality was observed between PCI and CABG irre-
spective of SYNTAX score strata (Figure 1). Similar ﬁndings were
observed for cardiovascular mortality (SS  32 RR 0.85; 95% 0.41-1.77;
I2 66% for PCI vs. CABG; SS >33 RR 1.25; 95% CI 0.92-1.69; I2 29% for
PCI vs. CABG).
CONCLUSIONS Patients with LM disease appear to have similar risks
of mortality after PCI with DES or CABG regardless of coronary artery
disease burden or complexity during long term follow up.CATEGORIES CORONARY: PCI Outcomes
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BACKGROUND Intense investigation continued on the quality control
of primary percutaneous coronary intervention (PPCI) because of its
high morbidity and mortality. However, little study focused on the
death cause analysis in a large sample. This study is to describe the
current status of acute myocardial infarction treatment in the real
world, facilitate individualized preventive approach for in-hospital
death, and develop a successful quality control/improvement solution
for primary percutaneous coronary intervention in China.
METHODS Data of patients were obtained from Beijing Percutaneous
Coronary InterventionRegistry study (BJPCI Registry,NCT01417325). Each
in-hospital dead case was reviewed and analyzed in the Beijing Cardio-
vascular Intervention Quality Control and Improvement Center quarterly.
RESULTS The study included 19905 acute myocardial infarction patients
(attack tovisiting time< 72h) of 52 centers inBeijing area fromJan.1, 2010 to
Dec 31, 2013. Total in-hospitalmortalitywas 2.30% (total 458 dead cases, 56
cases excluded). Of the included 402 cases, average age was 70.411.2,
91.8%were ST elevatedmyocardial infarction and 55.7%were male. 81.3%
of death occurred during the ﬁrst week after the emergency procedure.
58.5% had anterior wall involved, and 41.5% located in inferior, posterior
wall or rightventricle.Averageattack tovisiting timewas7hour52minutes.
Of all causes of death, the disease severity itself (178, 69.2%) were the pri-
mary factors, including cardiogenic shock (146, 36.3%), mechanical com-
plications (113, 28.1%), and others (19, 4.7%); Followed by the procedure
factors (81, 20.1%), including early stent thrombosis (36, 9.0%), no reﬂow
(30,7.5%), acute thrombosis or embolism(6, 1.5%), perforation or dissection
(4, 1.0%), retroperitoneal hematoma(3, 0.7%) and acute side branch
closure(2, 0.5%); The thirdwas thecomorbidity factors (29, 7.2%), including
septic shock(11, 2.7%), cerebral infarction(10, 2.5%), pulmonary embo-
lism(5,1.2%) and multiple organ failure(3, 0.7%); The last was medicine
factors (14, 3.5%), including intracranial hemorrhage(8, 2.0%), massive
gastrointestinal hemorrhage(5, 1.2%) and anaphylactic shock (1, 0.2%).
47.3% (190) of the dead cases had some sort of medical defects, including
indication (4, 1.0%), rescue measures (60, 14.9%), strategy selection(107,
26.6%)orprocedure issue (19,4.7%).There isnosigniﬁcantdifferenceof the
mortality from 2010 to 2013 (2.23%, 2.55%, 1.94% and 2.48% respectively).
CONCLUSIONS Mortality of acute myocardial infarction remains high,
which have a variety of causes, by order of disease itself, procedure,
comorbidity and medicine factors. The three leading causes of death
were cardiogenic shock, mechanical complications and early stent
thrombosis. Analysis of death causes may contribute to facilitate
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control/improvement solution.
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BACKGROUND Both mini-crush and culotte stenting are considered
efﬁcacious options when percutaneous coronary intervention (PCI)
with a planned 2-stent strategy is necessary for unprotected left main
coronary artery (LMCA) disease. However, there are limited data
available regarding to the long-term clinical outcomes of each strategy.
METHODS A retrospective analysis was conducted from the Milan and
New-Tokyo (MITO) registry and included all patients that underwent
PCI to the unprotected LMCA with drug-eluting stents. Between July
2002 and November 2013, 225 patients were identiﬁed (135 patients
treated with the mini-crush technique, and 90 patients with culotte
stenting). The median follow-up period was 1263 (IQR 820–1847) days.
RESULTS The mini-crush group had worse baseline characteristics when
compared to the culotte group. SYNTAX score were higher in the mini-
crush group than in the culotte (SYNTAX score; 30.4  10.5 vs. 27.5  9.4,
p ¼ 0.04). Stents implanted to the side-branch (SB) were signiﬁcantly
smaller and shorter in themini-crush group compared to the culotte group
(SB stent diameter: 2.99 0.38 vs. 3.24 0.34mm, p< 0.001, and SB stent
length: 19.8  6.4 vs. 22.3  5.7 mm, p ¼ 0.004). Intravascular ultrasound
was utilized in 67% of all cases, and ﬁnal kissing balloon inﬂation was
performed in more than 97% in both groups. There were no signiﬁcant
differences inmajor adverse cardiac events (MACE) at 5-years (mini-crush
36.0% vs. culotte 41.4%, p ¼ 0.57). Main-branch (MB)-TLR tended to be
higher in the culotte group (mini-crush 4.0% vs. culotte 9.9% at 5-years,
p ¼ 0.10) although there were no signiﬁcant differences regarding to SB-
TLR. Notably, myocardial infarction (MI) and deﬁnite stent thrombosis
(ST) were signiﬁcantly more frequent in the culotte group (MI; mini-crush
0%vs. culotte 11.3%, log-rankp¼0.003, anddeﬁniteST;mini-crush0%vs.
culotte 6.3%, p ¼ 0.02, respectively). Multivariate Cox regression analysis
revealed that full stent coverage of the LMCA (HR 0.54; 95% CI: 0.32–0.92,
p ¼ 0.02) and SYNTAX score (HR 1.02; 95% CI: 1.00–1.05, p ¼ 0.05) were
independent predictors for MACE.
CONCLUSIONS The incidence of MACE and overall TLR were com-
parable between groups. However, the rates of MI and deﬁnite ST
were signiﬁcantly higher in the culotte group. Full stent coverage of
the LMCA may reduce the incidence of MACE when a two-stent
strategy is used for the treatment of unprotected LMCA disease.
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BACKGROUND There is still uncertainty about the durability of the
results of drug-eluting stents (DES) in real-world complex patients
(pts). We sought to provide the longest clinical follow-up data on
outcomes of unselected patients treated solely with DES.
METHODS The DESIRE registry is a prospective, single-center registry
encompassing all consecutive patients treated solely with DES since
May 2002. The primary goal is the very long-term occurrence of MACE
and stent thrombosis (ST). Patients were clinically followed at 1, 6 and
12 months and then annually. A multivariate model was built to
determine independent predictors of MACE and ST.RESULTS A total of 5,614 pts (8,825 lesions / 9,980 DES) were
included. The mean age was 64  11 years. DM was detected in 31.5%
and 41.8% presented with acute coronary syndrome (STEMI repre-
sented 16.8% of the cohort). Follow-up was obtained in 98.4% of the
patients (median 5.9 years). Currently, 78.9% of the population is free
of any MACE. Ischemia-driven TVR was performed in 7.3% of the
patients. Q-wave MI rate was only 1.7% while cumulative incidence of
deﬁnite/probable ST was 4.1%. Independent predictors of MACE were
initial presentation as ACS (HR 1,4; 95% CI, 1.1 to 1.7, p¼ 0.001), lesion
length >20mm (HR 1.4; 95% CI, 1.2 to 1.6, p<0.001), residual stenosis
(HR 1.02; 95% CI, 1.01 to 1.03, p<0.001), DM (HR 1.6; 95% CI, 1.1 to 2.2,
p¼ 0.006) and severe coronary calciﬁcation (HR 1.4; 95% CI, 1.1 to 1.8,
p¼ 0.004) while use of 2nd generation DES was protective (HR 0.7;
95% CI, 0,5 to 0.9, p¼ 0.007). Independent predictors of ST were PCI
for STEMI (HR 2.6; 95% CI, 1.6 to 4.3, p<0.001) and treatment of small
vessels (HR 2.0; 95% CI, 1.3 to 3.3, p¼0.002).
CONCLUSIONS In our single center experience, the use of DES was
associated with very long-term safety and effectiveness with accept-
able low rates of adverse clinical events, including ST. Treatment of
patients with ACS, in particular STEMI, increase the risk of adverse
events while use of 2nd generation DES might be protective.
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BACKGROUND Despite the data from controlled trials pointing to
improved clinical results with 2nd generation DES as compared to the
1st generation, there is still a paucity of information on their long-
term performance in the “real-world” clinical practice.
METHODS The DESIRE registry is a prospective, single-center registry
with all consecutive patients (pts) treated with DES since May 2002.
To compare the outcomes of pts treated with 1st and 2nd generation
DES, a propensity score model was built to minimize the difference
between the cohorts. The primary endpoint was the comparison of
MACE and stent thrombosis (ST) up to 2 years of follow-up.
RESULTS A total of 5,614 pts were enrolled in the DESIRE. After
propensity score adjustment, the outcomes of 1,135 pairs of pts treated
with 1st and 2nd generation DES were compared. The cohorts were
comparable in terms of clinical proﬁle, with relatively high incidence
of diabetics (33%) and STEMI pts (17%). Conversely, 2nd generation
pts had more LM disease (1.1% vs. 2.3%, p¼0.005), ostial lesions (3.8%
vs. 6.5%, p<0.001) and bifurcations (7.2% vs. 10.3%, p<0.001). In
terms of clinical performance, there was no signiﬁcant difference in
MACE (Figure, panel A) and TLR between the groups, although 2nd
generation DES signiﬁcantly reduced MI (Figure, panel B), and tended
to reduce ST (Figure, panel C).
